Biomedical Regulatory Consulting (BRC) is a Houston-based drug and device regulatory affairs company with extensive experience in product development of medical therapies and medical devices. Drug and Device Development: BRC creates and manages reliable, credible, cost-efficient, and time-dependable regulatory paths to market for drugs and medical devices. BRC's drug and device development and management teams are staffed by qualified experts experienced in every phase and aspect of drug and device development and quality deployment of clinical studies, From extensive experience in leading drug and device development teams, BRC Founder and President, Dr. Bill Soller, designed the BRC project team system to ensure the reliable deployment of credentialed experts, the application of strong central management oversight, and use of a proprietary quality control system for client deliverables. Clinic Site Management: BRC addresses gaps in clinical site management for clients, emphasizing effective deployment of a proven quality-system management structure. BRC creates time-saving IT solutions for ensuring high quality agency-compliant BRC services for clinical trials associated with drug and device development programs. BRC uses a quality management systems approach created by Dr. Bill Soller for medical center clinical sites that he ran during his time at the University of California San Francisco. Founded by: BRC was founded by Dr. Bill Soller, a nationally recognized expert in drug safety, regulatory affairs for drug and device development, and clinical site management. From extensive experience in leading drug and device development teams, Dr. Bill Soller designed the BRC project team system to ensure the reliable deployment of credentialed experts, the application of strong central management oversight, and use of a proprietary quality control system for client deliverables.